Mother-to-child human leukocyte antigen G concordance: No impact on the risk of vertical transmission of HIV-1

AIDS

Volumn 16, Issue 18, 2002, Pages 2491-2494

  Matte, Claudine ^a   Zijenah, Lynn S ^b   Lacaille, Julie ^a   Ward, Brian ^c   Roger, Michel ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIV OF ZIMBABWE MEDICAL SCHOOL   (Zimbabwe)

^c MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN G; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PRIORITY JOURNAL; TROPHOBLAST; VERTICAL TRANSMISSION; ZIMBABWE;

DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HLA ANTIGENS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS;

EID: 0037032943     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200212060-00021     Document Type: Article

References (22)

1. Soeiro R, Rubinstein A, Rashbaum WK, Lyman WD. Maternofetal transmission of AIDS: Frequency of human immunodeficiency virus type 1 nucleic acid sequences in human fetal DNA. J Infect Dis 1992; 166:699-703.
2. Bertolli J, St Louis ME, Simmonds RJ, Neiburg P, Kamenga M, Brown C, et al. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in breast-feeding population in Kinshasa, Zaire. J Infect Dis 1996; 174:722-726.
3. Kuhn L, Abrams EI, Matheson PB, Thomas PA, Lambert G, Bamji M, et al. Timing of maternal-infant HIV transmission: Associations between intrapartum factors and early polymerase chain reaction results. AIDS 1997; 11:429-435.
4. Khun L, Stein ZA. Mother-to-infant HIV transmission: Timing, risk factors and prevention. Paediatr Perinat Epidemiol 1995; 9:1-29.
5. Mofenson LM. Mother-child HIV-1 transmission. Obstet Gynecol Clin North Am 1997; 24:759-785.
6. Zorrilla CD. Obstetric factors and mother-to-infant transmission of HIV-1. Infect Dis Clin North Am 1997; 11:109-118.
7. Hermione Lyall EG, Tudor-Williams G. Perinatal transmission of HIV. Curr Opin Infect Dis 1997; 10:239-245.
8. Matte C, Roger M. Genetic determinants of pediatric HIV-1 infection: Vertical transmission and disease progression among children. Mol Med 2001; 7:583-589.
9. Le Bouteiller P, Lenfant F. Gène HLA-G: Le plus classique des non classiques. Medecine/Sciences 1997; 13:1436-1444.
10. Ober C, Aldrich CL. HLA-G polymorphisms: Neutral evolution or novel function? J Reprod Immunol 1997; 36:1-21.
11. Pazmany L, Mandelboim O, Vales-Gomez M, Davis DM, Reyburn HT, Strominger JL. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 1996; 274:792-795.
12. Soderstrom K, Corliss B, Lanier LL, Phillips IH. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by the decidual and peripheral blood NK cells. J Immunol 1997; 159:1072-1075.
13. Rouas-Freiss N, Marchal-Bras Goncalves R, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A 1997; 94:11520-11525.
14. Ponte M, Cantoni C, Biassoni R, Tradori-Cappai A, Bentivoglio G, Vitale C, et al. Inhibitory receptors sensing HLA-G1 molecules in pregnancy; Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci U S A 1999; 96:5674-5679.
15. Lewis SH, Reynolds-Kohler C, Fox HE, Nelson JA. HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses. Lancet 1990; 335:565-568.
16. Kesson AM, Fear WR, Kazazi F, Mathijs JM, Chang J, King JC, et al. Human immunodeficiency virus type 1 infection of human placental macrophages in vitro. J Infect Dis 1993; 168:571-579.
17. Aikhionbare FO, Hodge T, Kuhn L, Bulterys M, Abrams EJ, Bond VC. Mother-child discordance in HLA-G exon 2 is associated with reduced risk of perinatal HIV-1 transmission. AIDS 2001; 15:2196-2198.
18. Bryson YJ, Luzuriaga K, Wara DW. Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med 1992; 327:1246-1247.
19. Le Bouteiller P. HLA-G: On the track of immunological functions. Eur J Immunogenet 1997; 24:397-408.
20. Suarez MB, Morales P, Castro MI, Ferandez V, Varela P, Alvarez M, et al. A new HLA-G allele (HLA-G*0105N) and its distribution in the Spanish population. Irnmunogenetics 1997; 45:464-465.
21. Matte C, Lacaille J, Zijenah LS, Ward B, and the Zvitambo Study Group, Roger M. HLA-G and HLA-E polymorphisms in an indigenous African population. Hum Immunol 2000; 61:1150-1156.
22. Ober C, Rosinsky B, Grimsley C, Van der Ven K, Robertson A, Runge A. Population genetic studies of HLA-G: Allele frequencies and linkage disequilibrium with HLA-A. J Reprod Immunol 1996; 32:111-123.